BALLIU, MANJOLA
 Distribuzione geografica
Continente #
EU - Europa 1.036
NA - Nord America 637
AS - Asia 132
AF - Africa 5
SA - Sud America 2
Totale 1.812
Nazione #
PL - Polonia 684
US - Stati Uniti d'America 636
RU - Federazione Russa 117
IE - Irlanda 59
IT - Italia 56
HK - Hong Kong 48
SE - Svezia 46
SG - Singapore 24
CN - Cina 21
CH - Svizzera 17
DE - Germania 16
FI - Finlandia 14
VN - Vietnam 13
GB - Regno Unito 12
IN - India 12
BE - Belgio 8
JO - Giordania 7
CI - Costa d'Avorio 5
KR - Corea 4
UA - Ucraina 3
AR - Argentina 2
ES - Italia 2
NL - Olanda 2
TR - Turchia 2
CA - Canada 1
TW - Taiwan 1
Totale 1.812
Città #
Warsaw 684
Fairfield 92
Dublin 59
Ashburn 54
Chandler 54
Ann Arbor 53
Woodbridge 49
Cambridge 48
Houston 47
Seattle 44
Hong Kong 34
Wilmington 25
Lawrence 20
Altamura 19
Florence 18
Bern 17
New York 16
Singapore 16
Princeton 15
Beijing 13
Dong Ket 13
Bremen 12
Mumbai 10
Brussels 8
Buffalo 8
Boston 7
Medford 7
San Diego 7
Boardman 6
Abidjan 5
Kent 5
Phoenix 5
Santa Clara 5
Shanghai 5
Helsinki 4
Seoul 4
Jacksonville 3
Lappeenranta 3
Los Angeles 3
Barcelona 2
Cipolletti 2
Falls Church 2
Izmir 2
Maranello 2
Moscow 2
Norwalk 2
Pisa 2
Rimini 2
Rome 2
Andover 1
Caronno Pertusella 1
Fiesole 1
Fontebuona 1
Munich 1
New Taipei City 1
Pune 1
Salerno 1
Schiavon 1
Toronto 1
Wandsworth 1
Yubileyny 1
Totale 1.529
Nome #
HDAC1 controls CIP2A transcription in human colorectal cancer cells 252
HDAC-inhibitor (S)-8 disrupts HDAC6-PP1 complex prompting A375 melanoma cell growth arrest and apoptosis. 232
Effectiveness of the histone deacetylase inhibitor (S)-2 against LNCaP and PC3 human prostate cancer cells 229
Mechanistic insight into WEB-2170-induced apoptosis in human acute myelogenous leukemia cells: the crucial role of PTEN 224
Inhibitors of the PI3K/mTOR pathway prevent STAT5 phosphorylation in JAK2V617F mutated cells through PP2A/ CIP2A axis 157
Calreticulin Ins5 and Del52 mutations impair unfolded protein and oxidative stress responses in K562 cells expressing CALR mutants 153
The new low-toxic histone deacetylase inhibitor S-(2) induces apoptosis in various acute myeloid leukemia cells 146
Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: Pathogenetic insight and diagnostic value 111
Design, synthesis and preliminary evaluation of a series of histone deacetylase inhibitors carrying a benzodiazepine ring 100
Activated IL-6 signaling contributes to the pathogenesis of, and is a novel therapeutic target for, CALR-mutated MPNs 57
Nanopore sequencing for the screening of myeloid and lymphoid neoplasms with eosinophilia and rearrangement of PDGFRα, PDGFRβ, FGFR1 or PCM1-JAK2 52
The Response to Oxidative Damage Correlates with Driver Mutations and Clinical Outcome in Patients with Myelofibrosis 35
Phenotypic correlations of CALR mutation variant allele frequency in patients with myelofibrosis 29
Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model 25
CALR mutation burden in essential thrombocythemia and disease outcome 20
Inhibition of CXCR1/2 reduces the emperipolesis between neutrophils and megakaryocytes in the Gata1low model of myelofibrosis 19
Immunoblotting-assisted assessment of JAK/STAT and PI3K/Akt/mTOR signaling in myeloproliferative neoplasms CD34+ stem cells 10
Totale 1.851
Categoria #
all - tutte 5.144
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.144


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020324 0 0 0 25 52 46 34 57 36 23 46 5
2020/2021286 19 40 1 45 21 35 18 22 24 34 8 19
2021/202296 3 6 12 2 3 4 2 13 6 7 15 23
2022/2023284 23 65 16 24 15 42 37 9 17 7 12 17
2023/2024152 2 10 17 4 14 31 1 44 1 8 11 9
2024/2025175 28 94 49 4 0 0 0 0 0 0 0 0
Totale 1.851